The Development and Validation of EMPOWER-UP: a Generic Questionnaire for Measuring Empowerment in Patient-provider Relationships

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Recruiting
CT.gov ID
NCT05277805
Collaborator
King's College London (Other), Deakin University (Other)
720
3
43.7
240
5.5

Study Details

Study Description

Brief Summary

Empowerment is widely acknowledged as an important approach in long-term care. The concept relates to the individual's ability to manage their own life and make rational decisions. Despite good intentions of working empowerment-based, research has shown that it can be difficult to realize and achieve in everyday practice within the healthcare system. To this date, no measurement instrument (questionnaire) exists that evaluate people's perceptions of whether their relationship with a healthcare provider promotes their empowerment process. The EMPOWER-UP questionnaire was therefore developed to provide such a measure. The EMPOWER-UP study aims to finalize the development process of the questionnaire and to test whether it is a valid and reliable measure.

People at the age of 18 years or above can participate if they have ever been diagnosed with a type of cancer, diabetes, or a mental illness and because of that diagnosis have been in contact with the healthcare system within the past six months.

The study is conducted online and requires participants to fill out an online questionnaire on a single occasion. Participation is expected to take no more than 10-15 minutes.

By participating, people may experience an increased awareness as to the nature of their interactions with healthcare providers. For some, this awareness may be beneficial and may alone enable them to ask for better care, while others may experience it as a burden if they are not able to seek better care.

By participating, people are helping to ensure that EMPOWER-UP will be a good questionnaire that may help raise awareness of the quality of relationships within the healthcare system and in term lead to better care.

The study is led by a team of researchers at the Danish University Hospital Rigshospitalet and the University of Copenhagen, Denmark.

The UK lead of the study is located at King's College London, UK. The Australian lead of the study is located at Deakin University, Melbourne, Australia.

This study is financially supported by the Novo Nordisk Foundation's Steno Collaborative Grant and by the Trygfonden foundation (Denmark)

Condition or Disease Intervention/Treatment Phase
  • Other: EMPOWER-UP questionnaire

Study Design

Study Type:
Observational
Anticipated Enrollment :
720 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
The Development and Validation of EMPOWER-UP: a Generic Questionnaire for Measuring Empowerment in Patient-provider Relationships
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
May 1, 2023
Anticipated Study Completion Date :
Aug 23, 2023

Arms and Interventions

Arm Intervention/Treatment
EMPOWER-UP participants

People with cancer, diabetes, or mental disorders answering the EMPOWER-UP questionnaire

Other: EMPOWER-UP questionnaire
Participants are asked to respond to the EMPOWER-UP questionnaire to test the psychometric properties of the questionnaire.

Outcome Measures

Primary Outcome Measures

  1. Relational empowerment [Baseline]

    EMPOWER-UP questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ever diagnosed with cancer, diabetes, or a mental disorder AND have had an interaction with a healthcare provider concerning their cancer/diabetes/mental disorder diagnosis within the past six months (relating to e.g. treatment or follow-up consultations)
Exclusion Criteria:
  • Unable to read and understand Danish (for danish participants) or English (for UK and australian participants)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Deakin University, Online Melbourne Australia
2 Rigshospitalet, online Copenhagen Denmark
3 King's College London, online London United Kingdom

Sponsors and Collaborators

  • Rigshospitalet, Denmark
  • King's College London
  • Deakin University

Investigators

  • Study Chair: Vibeke Zoffmann, Professor, Rigshospitalet, Denmark

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Emilie Haarslev Schröder Marqvorsen, Ph.d. student, MSc, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT05277805
Other Study ID Numbers:
  • P-2020-706
First Posted:
Mar 14, 2022
Last Update Posted:
Mar 14, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2022